Sanofi-Aventis SA (Sanofi-Aventis) has spent over $1.8 million for lobbying the US federal government in the third quarter of 2008. Sanofi-Aventis lobbied on issues related to the Medicaid program and on a bill that would extend a research and development tax credit. The company also lobbied on a bill to provide better coverage for mental health and addiction treatment.

The company spent over $1.2 million on lobbying in the third quarter of 2008, while the company’s vaccine division, Sanofi Pasteur Inc. of Swiftwater, Pa., spent $565,000.

The US subsidiary lobbied on issues related to men’s health, cancer awareness, diabetes care and treatment of life-threatening blood clots called deep vein thrombosis.

Meanwhile, the vaccine division lobbied on a host of issues, including vaccine safety funding, vaccines for children, influenza vaccine shortage issues, pandemic concerns, bioterrorism countermeasures and vaccine injury compensation programs.

The two subsidiaries lobbied Congress, the departments of the Veterans Affairs, Homeland Security and Health and Human Services, and the Executive Office of the President, according to a report filed October 17,2008 with the House clerk’s office.

People registered to lobby for Sanofi Pasteur included: Sean Callinicos, previously chief counsel to a Senate Environment and Public Works subcommittee and general counsel to former Sen. Lauch Faircloth, R-N.C.; Stuart Feldman, former legislative assistant to Sen. Orrin G. Hatch, R-Utah; and MaryAnne Dunlap, ex-staff member of the Senate Environment and Public Works Committee.